Data / Form D filings / Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp.: Form D filings
Phio Pharmaceuticals Corp., a biotechnology company in King Of Prussia, PA, filed 18 Form D notices with the SEC between 2013 and 2025. The latest, on November 12, 2025, reports $1.4 million sold of a $25.9 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 411 SWEDELAND ROAD, SUITE 23-1080, King Of Prussia, PA, 19406
- Phone
- (760) 943-1088
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1533040
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | New notice | $25,931,342 | $1,415,796 | $24,515,546 | 5 | Nov 4, 2025 | sec.gov |
| Aug 4, 2025 | New notice | $5,080,826 | $232,149 | $4,848,677 | 2 | Jul 28, 2025 | sec.gov |
| Jan 28, 2025 | New notice | $3,660,000 | $152,500 | $3,507,500 | 4 | Jan 17, 2025 | sec.gov |
| Jan 28, 2025 | New notice | $5,000,010 | $208,334 | $4,791,676 | 4 | Jan 15, 2025 | sec.gov |
| Jan 28, 2025 | New notice | $6,382,020 | $265,918 | $6,116,102 | 4 | Jan 14, 2025 | sec.gov |
| Jan 7, 2025 | New notice | $480,000 | $30,000 | $450,000 | 4 | Dec 24, 2024 | sec.gov |
| Jan 3, 2025 | New notice | $1,314,650 | $54,649 | $1,260,001 | 4 | Dec 20, 2024 | sec.gov |
| Jul 24, 2024 | New notice | $6,358,543 | $136,322 | $6,222,221 | 8 | Jul 11, 2024 | sec.gov |
| Dec 19, 2023 | New notice | $5,399,124 | $532,563 | $4,866,561 | 4 | Dec 8, 2023 | sec.gov |
| Jun 13, 2023 | New notice | $10,907,728 | $2,999,373 | $7,908,355 | 3 | Jun 2, 2023 | sec.gov |
| May 2, 2023 | New notice | $4,010,519 | $4,010,519 | 3 | Apr 20, 2023 | sec.gov | |
| Nov 23, 2022 | New notice | $1,750 | $1,750 | 1 | Nov 16, 2022 | sec.gov | |
| Feb 16, 2021 | New notice | $24,264,137 | $14,001,909 | $10,262,228 | 14 | Jan 25, 2021 | sec.gov |
| Apr 14, 2020 | New notice | $4,375,011 | $4,375,011 | 10 | Apr 2, 2020 | sec.gov | |
| Feb 24, 2020 | New notice | $1,903,128 | $1,903,128 | 6 | Feb 6, 2020 | sec.gov | |
| Aug 17, 2018 | Amendment | $15,261,000 | $1,937,904 | $13,323,096 | 1 | Aug 8, 2017 | sec.gov |
| Aug 18, 2017 | New notice | $15,261,000 | $261,000 | $15,000,000 | 1 | Aug 8, 2017 | sec.gov |
| Mar 26, 2013 | New notice | $23,628,750 | $23,628,750 | 35 | Mar 12, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Curtis A. Lockshin, Ph.D. | Director | |
| Patricia A. Bradford | Director | |
| Robert J. Bitterman | Director, Executive Officer | |
| Lisa H. Carson | Executive Officer | |
| David H. Deming | Director | |
| Jonathan A. Freeman | Director |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Nov 10, 2025 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Phio Pharmaceuticals Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.